Residual Limb Hyperhidrosis in Prosthetic Users: First Prospective Pilot of Topical Antiperspirant Treatment
JEADV Clinical Practice · 28.05.2026
DOI: 10.1002/jvc2.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift JEADV Clinical Practice, online erschienen am 28.05.2026. Verfasst von Jette Schack und 3 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sophies Minde Ortopedi.
Abstract (Originalsprache)
Background
Residual limb hyperhidrosis (RLH) is a frequent and debilitating condition among lower‐limb prosthetic users. Although aluminium chloride is recommended first‐line for focal hyperhidrosis, its efficacy in RLH has not previously been evaluated in prospective studies.
Objectives
To assess the effectiveness of 15% aluminium chloride for RLH using standardized clinical and patient‐reported outcomes.
Methods
This single‐centre, prospective pilot study enroled seven transtibial amputees; six completed the 4‐week intervention (one discontinued due to localized dermatitis). Participants applied 15% aluminium chloride nightly to sweating areas identified by the Minor (iodine–starch) test combined with the Sweating Intensity Visual Scale (SIVS), reducing application frequency once improvement occurred. Outcomes included the Hyperhidrosis Disease Severity Scale (HDSS), Minor/SIVS grading and a 0–100 Numerical Rating Scale (NRS) assessing sweating and functional impact. Pre–post changes were analysed using Wilcoxon tests or paired t ‐tests with Cohen's d effect sizes.
Results
Five of six completers (83%) achieved a ≥ 1‐point HDSS improvement ( p = 0.034), corresponding to ≥ 50% sweat reduction. SIVS scores decreased from a median of 2.5−1.0 ( p = 0.313). Significant NRS improvements were observed for perceived sweating (mean −32.5, p = 0.031, d = 1.05), functional interference (−46.7, p = 0.031, d = 1.41) and activity level (−33.3, p = 0.043, d = 1.08). Nonsignificant trends were seen for quality of life, gait stability and skin quality.
Conclusions
This study suggests that topical aluminium chloride may reduce RLH and improve prosthesis comfort and function. Targeted application guided by the Minor test produced clinically meaningful improvement in most participants. Larger controlled trials are needed to confirm efficacy and support evidence‐based RLH management.
Förderung
- Sophies Minde Ortopedi
Zitieren
APA
Schack, J., Endre, K. M. A. S., Ritchie, A., & Steen, H. (2026). Residual Limb Hyperhidrosis in Prosthetic Users: First Prospective Pilot of Topical Antiperspirant Treatment. JEADV Clinical Practice. https://doi.org/10.1002/jvc2.70365
Vancouver
Schack J, Endre KMAS, Ritchie A, Steen H. Residual Limb Hyperhidrosis in Prosthetic Users: First Prospective Pilot of Topical Antiperspirant Treatment. JEADV Clinical Practice. 2026. doi:10.1002/jvc2.70365
BibTeX
@article{Schack2026,
author = {Schack, Jette and Endre, Kim Magnus Advocaat Sandberg and Ritchie, Andrew and Steen, Harald},
title = {Residual Limb Hyperhidrosis in Prosthetic Users: First Prospective Pilot of Topical Antiperspirant Treatment},
journal = {JEADV Clinical Practice},
year = {2026},
doi = {10.1002/jvc2.70365}
}
EUVIMED